MetLife Investment Advisors »

Amicus Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1M 149k 14.19
2023-09-30 $1.8M 149k 12.16
2023-06-30 $1.9M 149k 12.56
2023-03-31 $1.6M 146k 11.09
2022-12-31 $1.8M 146k 12.21
2022-09-30 $1.5M 146k 10.44
2022-06-30 $1.6M 146k 10.74
2022-03-31 $1.4M 146k 9.47
2021-12-31 $1.1M 95k 11.55
2021-09-30 $906k 95k 9.55
2021-06-30 $915k 95k 9.64
2021-03-31 $825k 84k 9.89
2020-12-31 $2.4M 105k 23.09
2020-09-30 $1.6M 113k 14.12
2020-06-30 $1.7M 113k 15.08
2020-03-31 $1.0M 113k 9.24
2019-12-31 $1.1M 113k 9.74
2019-09-30 $904k 113k 8.02
2019-06-30 $1.1M 86k 12.48
2019-03-31 $1.2M 86k 13.60
2018-12-31 $821k 86k 9.58
2018-09-30 $1.6M 133k 12.09
2018-06-30 $1.3M 86k 15.62
2018-03-31 $1.3M 86k 15.04
2017-12-31 $1.1M 77k 14.39